Infectious Diseases
Conference Coverage
16 toddlers with HIV at birth had no detectable virus 2 years later
“We’re confirming here that the first step toward remission and cure is reducing reservoirs. We’ve got that here.”
Conference Coverage
A third person living with HIV has been cured by transplant
“There was no GVH disease. That’s incredible. It’s a wonderful thing.”
Opinion
A 34-year-old male presented with 10 days of a pruritic rash
A patient presents with targetoid erythematous papules and vesicles on his extremities and trunk, genital lesions, scaly bullous lesions...
News from the FDA/CDC
Children and COVID: Weekly cases down by more than half
As the effects of Omicron diminish, so does interest in vaccination.
Latest News
Ear tubes not recommended for recurrent AOM without effusion, ENTs maintain
Guideline update reaffirms importance of attention to at-risk children with otitis media with effusion.
Opinion
Treatment duration for acute otitis media – so many choices
Even though the number of potential antibiotics has contracted in the past 20 years, the need to individualize AOM treatment remains important and...
News from the FDA/CDC
Small group of higher-volume antibiotic prescribers identified
Top 10% of Medicare providers “wrote a median of 284 antibiotic prescriptions, compared with a median of 41 among lower-volume prescribers” in...
Latest News
Strep infection and tics in children: new data
If preteens present with a new-onset tic condition, “they’re unlikely to have it as a result of a group A streptococcal throat infection.”
Latest News
Review finds anti-staphylococcus treatments have little impact on eczema
In four studies, oral antibiotics “may make no difference in terms of good or excellent global improvement in infants and children at 14 to 28...
News from the FDA/CDC
Children and COVID: New cases down again, but still ‘extremely high’
After 3 months, the vaccination of 5- to 11-year-olds is falling behind that of older children.
From the Journals
Infant bronchiolitis subtype may predict asthma risk